Therapy (HCV)
Extended Interferon Beats Standard Dosing For Sustained Response
Published in Hepatitis Weekly, March 26th, 2001
A report from The Netherlands indicates initial relapsers to standard interferon regimens regain viral response by extending treatments up to 36 months.
M. Damen et al., Academic Medical Center, performed a controlled, randomized trial of 88 patients that compared the efficacy of standard interferon treatment, lasting 24 weeks, with long-term treatment, which extended up to 156 weeks, depending upon patient response.
In the standard regimen, patients were given an induction dose of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-03-26)
More Articles from Hepatitis Weekly
- Hemodialysis
Liver Enzyme Test Inadequate For Screening Patients For HCV - Pathogenesis
Differential Profiles Mark Genetics Of Hepatitis B And C - Transmission
Pigs Are Reservoir For Hepatitis E Virus And Infection Risk For Humans - Diagnostics
Outpatient Liver Biopsy Convenient, Reduces Costs - Disease Associations
Hepatitis B and C Linked To Non-Hodgkin's Lymphoma In Japan - Epidemiology
High Rates Of HBV And HCV Are Blamed For Growing Incidence of Liver Cancer In Egypt - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
